Summary
The isolated perfused rat brain was used for a comparative study of the effects of promazine, imipramine, monodesmethyl promazine and desipramine on cerebral energy metabolism. After perfusion for 30 min or 1 h the brain levels of the following substrates and metabolites were estimated: P-creatine, creatine, ATP, ADP, AMP, glycogen, glucose, glucose-6-P, fructose diphosphate, dihydroxyacetone-P, pyruvate, lactate, α-ketoglutarate, and ammonia. Drug concentrations of 5·10−6 M and 10−5 M in the perfusion medium caused a significant decrease of glucose-6-P alone. When the drug concentration was raised to a toxic range (10−4 M), reflected in the EEG by the pattern of secondary discharges, an accumulation of P-creatine and glucose and a decrease of glycogen, glucose-6-P and ammonia occurred; the lactate/pyruvate ratios remained unchanged. As there were no qualitative differences between the effects of the investigated neuroleptics and antidepressants on cerebral metabolism, these effects might be unspecific and not correlated with the pharmacological action of the drugs.
Similar content being viewed by others
References
Akera, T., Brody, T. M.: Inhibition of brain sodium- and potassium-stimulated adenosine triphosphatase activity by chlorpromazine free radical. Molec. Pharmacol. 4, 600–612 (1968)
Andjus, R. K., Suhara, K., Sloviter, H. A.: An isolated, perfused rat brain preparation, its spontaneous and stimulated activity. J. appl. Physiol. 22, 1033–1039 (1967)
Berger, M.: Metabolic reactivity of brain and liver mitochondria towards chlorpromazine. J. Neurochem. 2, 30–36 (1957)
Bergmeyer, H. U.: Methoden der enzymatischen Analyse, 2. Aufl. Weinheim: Verlag Chemie 1970
Bernsohn, J., Namajuska, I., Cochrane, L. S. G.: The effect of chlorpromazine on respiration and glycolysis in rat brain. Arch. Biochem. Biophys. 62, 274–283 (1956)
Brunner, E. A., Passonneau, J. V., Molstad, C.: The effect of volatile anaesthetics on levels of metabolites and on metabolic rate in brain. J. Neurochem. 18, 2301–2316 (1971)
Carver, M. J.: Differential effects of phenothiazines on hexose phosphate dehydrogenases. Biochem. Pharmacol. 12, 19–24 (1963)
Chowdhury, A. K., Skinner, A., Spector, R. G., Yap, S.-L.: The effect of chlorpromazine on cerebral glucose, ATP, ADP, AMP and ATPase in the mouse. Brit. J. Pharmacol. 34, 70–75 (1968)
Chowdhury, A. K., Spector, R. G.: The influence of psychotropic drugs and ambient temperature on glycogen and reducing substances in mouse brain and liver. Biochem. Pharmacol. 18, 1248–1251 (1969)
Curry, S. H.: The determination and possible significance of plasma levels of chlorpromazine in psychiatric patients. Aggressologie 9, 115–121 (1968)
Dawkins, M. J. R., Judah, J. D., Rees, K. R.: The effect of chlorpromazine on the respiratory chain. Biochem. J. 72, 204–209 (1959)
Dempsey, E. W., Morison, R. S.: Some afferent diencephalic pathways related to cortical potentials in the cat. Amer. J. Physiol. 131, 718–731 (1941)
Estler, C.-J.: Glykogengehalt des Gehirns und Körpertemperatur weißer Mäuse unter dem Einfluß einiger zentral dämpfender und erregender Pharmaka. Med. exp. (Basel) 4, 209–213 (1961)
Fleck, W., Krieglstein, J., Urban, W.: Zwei Apparaturen zur Perfusion des isolierten Rattenhirns. Arzneimittel-Forsch. 22, 1225–1230 (1972)
Fleming, M. C., LaCourt, S.: The comparative effect of γ-hydroxybutyrate and phenobarbital on brain energy metabolism. Biochem. Pharmacol. 14, 1905–1907 (1965)
Gey, K. F., Rutishauser, M., Pletscher, A.: Suppression of glycolysis in rat brain in vivo by chlorpromazine, reserpine, and phenobarbital. Biochem. Pharmacol. 14, 507–514 (1965)
Glasser, H., Krieglstein, J.: Die Eiweißbindung einiger Psychopharmaka mit tricyclischem Ringsystem in Abhängigkeit von ihrer chemischen Konstitution. Naunyn-Schmiedebergs Arch. Pharmak. 265, 321–334 (1970)
Granholm, L., Kaasik, A. E., Nilsson, L., Siesjö, B. K.: The lactate/pyruvate ratios of cerebrospinal fluid of rats and cats related to the lactate/pyruvate, the ATP/ADP, and the phosphocreatine/creatine ratios of brain tissue. Acta physiol. scand. 74, 398–409 (1968)
Grüner, J., Krieglstein, J., Rieger, H.: Comparison of the effects of chloral hydrate and trichloroethanol on the EEG of the isolated perfused rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 277, 333–348 (1973)
Hackenberg, H., Krieglstein, J.: Comparative study on the inhibition of Na+, K+-activated ATPase activity of chlorpromazine, promazine, imipramine, and their monodesmethyl metabolites. Naunyn-Schmiedeberg's Arch. Pharmacol. 274, 64–73 (1972)
Huang, C. L., Ruskin, B. H.: Determination of serum chlorpromazine metabolites in psychotic patients. J. nerv. ment. Dis. 139, 381–386 (1964)
Hutchins, D. A., Rogers, K. J.: Physiological and drug-induced changes in the glycogen content of mouse brain. Brit. J. Pharmacol. 39, 9–25 (1970)
Iriye, T. T., Simmonds, F. A.: Effect of chlorpromazine on rat brain phosphorylase. Int. J. Neuro-pharmacol. 6, 341–357 (1967)
Iriye, T. T., Simmonds, F. A.: Effect of tranquilizers and antidepressants on glycogen phosphorylase of rat brain. Biochem. Pharmacol. 20, 1889–1900 (1971)
Jähnchen, E., Krieglstein, J.: Die Aufnahme von Promazin, chlorpromazin und deren Desmethylmetaboliten in das isoliert perfundierte Rattenhirn. Naunyn-Schmiedebergs Arch. Pharmak. 268, 300–309 (1971)
Kanig, K.: Der Einfluß zentral wirksamer Substanzen auf den Nucleotid-Stoffwechsel des Gehirns. Habil.-Schrift, Med. Fakultät, Freie Universität Berlin 1963
Kaul, C. L., Lewis, J. J., Livingstone, S. D.: Influence of chlorpromazine on the levels of adenine nucleotides in the rat brain and hypothalamus in vivo. Biochem. Pharmacol. 14, 165–175 (1965)
Kraus, P., Šimáně, Z.: The influence of perathiepine and chlorpromazine on some enzyme reactions in rat brain preparations. Experientia (Basel) 23, 90–91 (1967)
Krieglstein, G., Krieglstein, J., Stock, R.: Suitability of the isolated perfused rat brain for studying effects on cerebral metabolism. Naunyn-Schmiedeberg's Arch. Pharmacol. 275, 124–134 (1972a)
Krieglstein, G., Krieglstein, J., Urban, W.: Long survival time of an isolated perfused rat brain. J. Neurochem. 19, 885–886 (1972b)
Krieglstein, J., Kuschinsky, G.: Quantitative Bestimmung der Eiweißbindung von Pharmaka durch Gelfiltration. Arzneimittel-Forsch. 18, 287–289 (1968)
Krieglstein, J., Stock, R.: Comparative study of the effects of chloral hydrate and trichloroethanol on cerebral metabolism. Naunyn-Schmiedeberg's Arch. Pharmacol. 277, 323–332 (1973)
Lewis, J. J., van Petten, G. R.: The effect of antidepressive drugs and some related compounds on the levels of adenine nucleotides, inorganic phosphate and phosphocreatine in the rat brain. Brit. J. Pharmacol. 20, 462–470 (1963)
March, J. E., Donato, D., Turano, P., Turner, W. J.: Interpatient variation and significance of plasma levels of chloropromazine in psychotic patients. J. Med. 3, 146–162 (1972)
Masurat, T., Greenberg, S. M., Rice, E. G., Herndon, J. F., van Loon, E. J.: The action of chlorpromazine on yeast hexokinase. Biochem. Pharmacol. 5, 20–26 (1960)
Máthé, V., Kassay, G.: Die Wirkung von Psychopharmaka auf den energetischen Stoffwechsel des Hirngewebes. Arzneimittel-Forsch. 19, 419–421 (1969)
Máthé, V., Kassay, G., Hunkár, K.: Die Wirkung des Chlorpromazins auf den Kohlenhydratstoffwechsel des Rattengehirns. Psychopharmacologia (Berl.) 2, 334–341 (1961)
Mayman, C. I., Gatfield, P. D., Breckenridge, B. McL.: The glucose content of brain in anaesthesia. J. Neurochem. 11, 483–487 (1964)
Minard, F. N., Davis, R. V.: Effect of chlorpromazine, ether, and phenobarbital on the active-phosphate level of rat brain: an improved extraction technique for acid-soluble phosphates. Nature (Lond.) 193, 277–278 (1962)
Pecháň, I.: Effects of psychopharmacological agents on brain metabolism. —II. Influence of imipramine and prothiadene on the free nucleotide level of rat brain. Biochem. Pharmacol. 14, 1651–1655 (1965)
Rutishauser, M.: Beeinflussung des Kohlenhydratstoffwechsels des Rattenhirns durch Psychopharmaka mit sedativer Wirkung. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 245, 396–413 (1963)
Schmahl, F. W., Betz, E., Talke, H., Hohorst, H. J.: Energiereiche Phosphate und Metabolite des Energiestoffwechsels in der Großhirnrinde der Katze. Biochem. Z. 342, 518–531 (1965)
Stock, R., Krieglstein, J., Rieger, H.: The effects of imipramine and promazine on energy metabolism and EEG of the isolated perfused rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol., Suppl. 277 R 77 (1973)
Turano, P., March, J. E., Turner, W. J., Merlis, S.: Qualitative and quantitative report on chlorpromazine and metabolites in plasma, erythrocytes and erythrocyte washings from chronically medicated schizophrenic patients. J. Med. 3, 109–120 (1972)
Wilson, W. S.: The effects of phenobarbitone, leptazol, dexamphetamine, iproniazid, imipramine, LSD, chlorpromazine, reserpine and hydroxyzine on the in vivo levels of adenine nucleotides and phosphocreatine in the rat brain. Brit. J. Pharmacol. 36, 448–457 (1969)
Wollemann, M., Keleti, T.: Über den Mechanismus der Dehydrogenase-Aktivitätshemmung der Phenothiazine. Arzneimittel-Forsch. 12, 360–363 (1962)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Krieglstein, J., Stock, R. & Rieger, H. Influence of therapeutic and toxic doses of neuroleptics and antidepressants on energy metabolism of the isolated perfused rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 279, 243–254 (1973). https://doi.org/10.1007/BF00500604
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00500604